Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.78 +0.12 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Unicycive Therapeutics (UNCY) Other Operating Expenses (2022 - 2023)

Updated

Unicycive Therapeutics (UNCY) reported Other Operating Expenses of $1.61 million for Q3 2023, compared with -$3,000 a year earlier and up 231.6% from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Other Operating Expenses (2022 - 2023) Analysis & Trends

Dating back to Q3 2022, Unicycive Therapeutics' Other Operating Expenses record includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Unicycive Therapeutics 101.95 Mn -98.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 1.61 Mn
Jun 30, 2023 484,000.00
Mar 31, 2023 -10.37 Mn
Sep 30, 2022 -3,000.00
API Access

Unicycive Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=UNCY&period=max&api_key=YOUR_API_KEY